Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Jazz Pharmaceuticals (JAZZ)
NASDAQ:JAZZ
JAZZ Analyst Ratings
Strong Buy
13 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
JAZZ Stock 12 Month Forecast
Average Price Target
$187.36
▲(38.83% Upside)
| Highest Price Target$230.00 | Average Price Target$187.36 | Lowest Price Target$163.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Wells Fargo
Upgraded
02/13/25
Bank of America Securities
Reiterated
02/11/25
Morgan Stanley
Reiterated
02/06/25
RBC Capital
Reiterated
01/07/25
Jefferies
Assigned
01/03/25
TD Cowen
Reiterated
12/17/24
Truist Financial
Assigned
12/13/24
Stifel Nicolaus
Reiterated
12/12/24
Needham
Reiterated
12/12/24
Piper Sandler
Reiterated
12/12/24
Leerink Partners
―
Buy
―
Reiterated
12/11/24
Analysts Conflicted on These Healthcare Names: Jazz Pharmaceuticals (NASDAQ: JAZZ), Acadia Healthcare (NASDAQ: ACHC) and Genmab (NASDAQ: GMAB)
Barclays
$190
Buy
40.78%
Upside
Assigned
11/22/24
Barclays Reaffirms Their Buy Rating on Jazz Pharmaceuticals (JAZZ)
H.C. Wainwright
$200
Buy
48.19%
Upside
Reiterated
11/21/24
Jazz Pharmaceuticals: Promising Growth Potential with Robust Pipeline and Undervalued Market Position
UBS
$121→$128
Hold
-5.16%
Downside
Reiterated
11/19/24
Jazz Pharmaceuticals (JAZZ) PT Raised to $128 at UBSUBS analyst Ashwani Verma raised the price target on Jazz Pharmaceuticals (NASDAQ: JAZZ) to $128.00 (from $121.00) while maintaining a Neutral rating.
Robert W. Baird
$162
Buy
20.04%
Upside
Assigned
11/17/24
Jazz Pharmaceuticals price target raised to $162 from $154 at BairdJazz Pharmaceuticals price target raised to $162 from $154 at Baird
Best Analysts Covering Jazz Pharmaceuticals
Which Analyst Should I Follow If I Want to Buy JAZZ and Sell After:
1 Month
xxx
Success Rate
24/36 ratings generated profit
Average Return
+1.05%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 66.67% of your transactions generating a profit, with an average return of +1.05% per trade.
3 Months
xxx
Success Rate
25/41 ratings generated profit
Average Return
+0.07%
reiterated a xxx
rating 10 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 60.98% of your transactions generating a profit, with an average return of +0.07% per trade.
1 Year
Success Rate
17/26 ratings generated profit
Average Return
+5.05%
reiterated a buy rating 2 months ago
Copying Annabel Samimy's trades and holding each position for 1 Year would result in 65.38% of your transactions generating a profit, with an average return of +5.05% per trade.
2 Years
xxx
Success Rate
17/29 ratings generated profit
Average Return
+5.01%
assigned a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 58.62% of your transactions generating a profit, with an average return of +5.01% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
JAZZ Analyst Recommendation Trends
Rating
Oct 24
Nov 24
Dec 24
Jan 25
Feb 25
Strong Buy
16
17
18
15
3
Buy
9
12
16
14
11
Hold
4
5
4
3
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
29
34
38
32
14
Each month's total comprises the sum of three months' worth of ratings.
JAZZ Financial Forecast
JAZZ Stock Forecast FAQ
What is JAZZ’s average 12-month price target, according to analysts?
Based on analyst ratings, Jazz Pharmaceuticals’s 12-month average price target is $187.36.
What is JAZZ’s upside potential, based on the analysts’ average price target?
Jazz Pharmaceuticals has 38.83% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is JAZZ a Buy, Sell or Hold?
Jazz Pharmaceuticals has a consensus rating of Strong Buy which is based on 13 buy ratings, 0 hold ratings and 0 sell ratings.
What is Jazz Pharmaceuticals’s price target?
The average price target for Jazz Pharmaceuticals is $187.36. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $230.00 ,the lowest forecast is $163.00. The average price target represents 38.83% Increase from the current price of $134.96.
The highest analyst price target is $230.00 ,the lowest forecast is $163.00. The average price target represents 38.83% Increase from the current price of $134.96.
What do analysts say about Jazz Pharmaceuticals?
Jazz Pharmaceuticals’s analyst rating consensus is a Strong Buy. This is based on the ratings of 13 Wall Streets Analysts.
How can I buy shares of JAZZ?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.